☰

Janet L. Oblinger, Ph.D. - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
pathobiology of brain cancer
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chang LS, Oblinger JL, Burns SS, Huang J, Anderson LW, Hollingshead MG, Shen R, Pan L, Agarwal G, Ren Y, Roberts RD, O'Keefe BR, Kinghorn AD, Collins JM. Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas. Molecular Cancer Therapeutics. PMID 31848295 DOI: 10.1158/1535-7163.Mct-19-0809  0.467
2018 Angus SP, Oblinger JL, Stuhlmiller TJ, DeSouza PA, Beauchamp RL, Witt L, Chen X, Jordan JT, Gilbert TSK, Stemmer-Rachamimov A, Gusella JF, Plotkin SR, Haggarty SJ, Chang LS, Johnson GL, et al. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro-Oncology. PMID 29982664 DOI: 10.1093/Neuonc/Noy046  0.318
2017 Oblinger JL, Burns SS, Huang J, Pan L, Ren Y, Shen R, Douglas Kinghorn A, Bradley Welling D, Chang LS. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Experimental Neurology. PMID 28610844 DOI: 10.1016/J.Expneurol.2017.06.015  0.425
2016 Oblinger JL, Burns SS, Akhmametyeva EM, Huang J, Pan L, Ren Y, Shen R, Miles-Markley B, Moberly AC, Kinghorn AD, Welling DB, Chang LS. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas. Neuro-Oncology. PMID 26951381 DOI: 10.1093/Neuonc/Now032  0.316
2013 Burns SS, Akhmametyeva EM, Oblinger JL, Bush ML, Huang J, Senner V, Chen CS, Jacob A, Welling DB, Chang LS. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Cancer Research. 73: 792-803. PMID 23151902 DOI: 10.1158/0008-5472.Can-12-1888  0.416
2012 Bush ML, Burns SS, Oblinger J, Davletova S, Chang LS, Welling DB, Jacob A. Treatment of vestibular schwannoma cells with ErbB inhibitors. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 33: 244-57. PMID 22222570 DOI: 10.1097/Mao.0B013E31823E287F  0.333
2012 Jacob A, Oblinger J, Bush ML, Brendel V, Santarelli G, Chaudhury AR, Kulp S, La Perle KM, Chen CS, Chang LS, Welling DB. Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas. The Laryngoscope. 122: 174-89. PMID 22109824 DOI: 10.1002/Lary.22392  0.351
2011 Bush ML, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva EM, Burns SS, Wheeler J, Davis J, Yates CW, Chaudhury AR, Kulp S, Chen CS, Chang LS, Welling DB, et al. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro-Oncology. 13: 983-99. PMID 21778190 DOI: 10.1093/Neuonc/Nor072  0.432
2010 Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, Guha A, Phipps RJ, Hock JM, Yu X. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Science. 101: 1997-2004. PMID 20550523 DOI: 10.1111/J.1349-7006.2010.01616.X  0.313
2006 Oblinger JL, Pearl DK, Boardman CL, Saqr H, Prior TW, Scheithauer BW, Jenkins RB, Burger PC, Yates AJ. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients. Neuropathology and Applied Neurobiology. 32: 410-8. PMID 16866986 DOI: 10.1111/J.1365-2990.2006.00742.X  0.386
2006 Saqr HE, Omran OM, Oblinger JL, Yates AJ. TRAIL-induced apoptosis in U-1242 MG glioma cells. Journal of Neuropathology and Experimental Neurology. 65: 152-61. PMID 16462206 DOI: 10.1097/01.Jnen.0000199574.86170.80  0.605
2006 Saqr HE, Omran O, Dasgupta S, Yu RK, Oblinger JL, Yates AJ. Endogenous GD3 ganglioside induces apoptosis in U-1242 MG glioma cells. Journal of Neurochemistry. 96: 1301-14. PMID 16441517 DOI: 10.1111/J.1471-4159.2005.03640.X  0.603
2003 Oblinger JL, Boardman CL, Yates AJ, Burry RW. Domain-dependent modulation of PDGFRbeta by ganglioside GM1. Journal of Molecular Neuroscience : Mn. 20: 103-14. PMID 12794304 DOI: 10.1385/Jmn:20:2:103  0.538
1999 Rampersaud AA, Oblinger JL, Ponnappan RK, Burry RW, Yates AJ. Gangliosides and growth factor receptor regulation. Biochemical Society Transactions. 27: 415-22. PMID 10917613 DOI: 10.1042/Bst0270415  0.476
Show low-probability matches.